Hims & Hers Health Class Action Lawsuit Notice
The Rosen Law Firm, a global investor rights law firm, has issued a notice reminding investors who purchased common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025, and June 23, 2025, of the important August 25, 2025, lead plaintiff deadline. The notice claims that the company made false and misleading statements about its collaboration with the pharmaceutical company Novo Nordisk A/S and its offering of compounded semaglutide products.
Key Takeaways:
- A class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) related to the company's collaboration with Novo Nordisk A/S and the offering of compounded semaglutide products.
- The lawsuit claims that the company made false and misleading statements about the collaboration and the availability of the weight-loss drug Wegovy to its subscribers.
- Investors who purchased Hims common stock between April 29, 2025, and June 23, 2025, may be entitled to compensation through a contingency fee arrangement.
- The Rosen Law Firm, which issued the notice, has a track record of success in securities class actions and was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017.
- The firm has secured over $438 million for investors in 2019 and was founded by Laurence Rosen, who was named a Titan of Plaintiffs' Bar by Law360 in 2020.
Statistics:
- The class period for the lawsuit is April 29, 2025, to June 23, 2025.
- The lead plaintiff deadline is August 25, 2025.
- Over $438 million was secured for investors by The Rosen Law Firm in 2019.
- The firm has participated in over 400 cases and recovered hundreds of millions of dollars for investors.
Sources:
- Newsfile Corp. (July 8, 2025) - https://www.newsfilecorp.com/release/258107
- The Rosen Law Firm (mentioned as a global investor rights law firm)
- ISS Securities Class Action Services (ranked The Rosen Law Firm No. 1 in 2017)
- Law360 (named Laurence Rosen a Titan of Plaintiffs' Bar in 2020)